Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peter C.Y. Tong"'
Autor:
Andrea O.Y. Luk, Peter C.Y. Tong, Juliana C.N. Chan, Xilin Yang, Alice P.S. Kong, Linda W.L. Yu, Wing-Yee So, Rose Z.W. Ting, Ronald C.W. Ma
Publikováno v:
Cardiovascular Diabetology, Vol 9, Iss 1, p 77 (2010)
Cardiovascular Diabetology
Cardiovascular Diabetology
Background Dyslipidaemia is an important but modifiable risk factor of cardiovascular disease (CVD) in type 2 diabetes. Yet, the effectiveness of lipid regulating drugs in Asians is lacking. We examined the effects of lipid control and treatment with
Autor:
Ronald C.W. Ma, Augustine Lui, Sau-chu Chiang, Gary T. Ko, Juliana C.N. Chan, Derek Stewart, Francis K.L. Chan, Alice P. Kong, Wing-Yee So, Peter C.Y. Tong, Wilson Y.S. Leung, Xilin Yang
Publikováno v:
Cardiovascular Diabetology
Cardiovascular Diabetology, Vol 8, Iss 1, p 57 (2009)
Cardiovascular Diabetology, Vol 8, Iss 1, p 57 (2009)
Background The risk-benefit ratio of aspirin therapy in prevention of cardiovascular disease (CVD) remains contentious, especially in type 2 diabetes. This study examined the benefit and harm of low-dose aspirin (daily dose < 300 mg) in patients with
Autor:
C. S. Ho, Gary T. Ko, Alice P. Kong, Wing-Yee So, Vivian C. W. Wong, Clive S. Cockram, Ronald C.W. Ma, Peter C.Y. Tong, Juliana C.N. Chan, Xilin Yang, Christopher W.K. Lam
Publikováno v:
Cardiovascular Diabetology, Vol 6, Iss 1, p 37 (2007)
Cardiovascular Diabetology
Cardiovascular Diabetology
Background Glycated haemoglobin (HbA1c), blood pressure and body mass index (BMI) are risk factors for albuminuria, the latter in turn can lead to hyperlipidaemia. We used novel statistical analyses to examine how albuminuria and chronic kidney disea